|
Join to add comments or your story
Seven Keys to Treating Prostate Cancer. Johns Hopkins .pdf
Dr. Peter Scardino's Prostate Book
by Peter Scardino and Judith Kelman $18.45
A Primer on Prostate Cancer: The Empowered Patient's Guide
by Stephen Strum, MD & Donna Pogliano. Paperback, 1s edition. $19.98..
Prostate & Cancer:
A Family Guide
to Diagnosis,
Treatment &
Survival
by Sheldon Marks MD Reference book for men concerned about or diagnosed with prostate cancer. $12.57
Raise a Voice, an advocacy group for advanced prostate cancer patients, which is calling for patient access to drugs that have passed through Phase I trials, has written a thank you letter to the FDA Advisory Committee on Dendreon’s sipuleucel-T (Provenge). The letter is signed by 19 prostate cancer advocacy groups including US Too International and National Prostate Cancer Coalition.
(full story…)
Dr. Thomas R. Fleming, Ph.D., a prostate cancer survivor and nationally recognized statistician specializing in clinical trials design and analysis, has written a letter urging FDA officials not to approve Dendreon’s application at this time.
Echoing concerns about post-hoc analysis expressed by FDA statistical reviewer Dr. Bo-Guang Zhen, Fleming disagrees with a prostate cancer survivor on the FDA’s March 29 advisory committee who said that Dendreon’s sipuleucel-T (Provenge) vaccine offers "an opportunity to make a choice."
Fleming writes: "As a fellow person living with prostate cancer I strongly disagree with [this] statement that all patients want is a ‘choice.’ Patients want an ‘informed choice.’”
